About Global Pharma Regulatory Consultancy
Global Pharma Regulatory Consultancy was a Healthcare company based in Ahmedabad (India) founded in 2018. It offers consulting services for pharmaceutical regulatory support. It operates on a B2B model. Its Indian entity Globofarm International Private Limited reported revenue of ₹29.28 Cr. The company is recorded as dissolved. Its focus areas include Healthcare and Pharmaceuticals, Consulting, Regulatory Affairs and Pharma Compliance.
Company details
Global Pharma Regulatory Consultancy, established in 2018, excels in healthcare and pharmaceuticals, offering consulting services, regulatory affairs, and pharma compliance. Offers consulting services for pharmaceutical regulatory support. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Ahmedabad, India
- SectorsHealthcare
- Website globalpharmaregulatory.com
- Legal Name Globofarm International Private Limited
- Date of Incorporation 17 Feb, 2020
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹29.28 Cr
FY 2026 · +20% YoY
- Net Profit₹36.5 Lakh
FY 2026 · 1% margin
- EBITDA₹1.31 Cr
FY 2026 · 5% margin
Associated legal entities of Global Pharma Regulatory Consultancy
Global Pharma Regulatory Consultancy operates through Globofarm International Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Globofarm International Private Limited CIN U51909MH2020PTC337865 | Active | 17 Feb 2020 | Mumbai, Maharashtra | ₹29.3 Cr | 2 | View details |
Board of directors of Globofarm International Private Limited (Global Pharma Regulatory Consultancy)
Globofarm International Private Limited is the primary company behind Global Pharma Regulatory Consultancy. The board of Globofarm International Private Limited currently have 2 directors; the longest-serving is Gronil Sanjay Jain, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gronil Sanjay Jain DIN 07844212 | Director | 17 Feb 2020 | 6 yrs 8 mo | Globofarm International Private Limited |
| Anushree Jain DIN 07844252 | Director | 17 Feb 2020 | 6 yrs 8 mo | Globofarm International Private Limited |
Financials of Global Pharma Regulatory Consultancy
Figures of Globofarm International Private Limited, the primary company behind Global Pharma Regulatory Consultancy, for FY 2026. Revenue was ₹29.28 Cr (+20% year on year). Net profit was ₹36.5 Lakh (1% margin). EBITDA was ₹1.31 Cr (5% margin). Revenue has grown at a compounded annual rate of +6% over three years and +22% over five years.
- ₹29.28 CrRevenue · FY 2026 · +20% YoY
- ₹36.5 LakhNet profit · 1% margin
- ₹1.31 CrEBITDA · 5% margin
- ₹1 LakhPaid-up capital
- +6%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Globofarm International Private Limited are on its company page.
Detailed financial statements for Global Pharma Regulatory Consultancy
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Global Pharma Regulatory Consultancy
Global Pharma Regulatory Consultancy was founded in 2018.
Global Pharma Regulatory Consultancy is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Global Pharma Regulatory Consultancy, Globofarm International Private Limited, reported revenue of ₹29.28 Cr for FY 2026, up 20% year on year.
Global Pharma Regulatory Consultancy, established in 2018, excels in healthcare and pharmaceuticals, offering consulting services, regulatory affairs, and pharma compliance. Offers consulting services for pharmaceutical regulatory support. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Global Pharma Regulatory Consultancy operates through Globofarm International Private Limited.
The legal entities of Global Pharma Regulatory Consultancy currently have 2 directors, including Gronil Sanjay Jain, Anushree Jain.